One size fits null: attentional brain responses differ depending on insomnia subtype
Wenrui Zhao1,2, Eus J W Van Someren2,3,4, Glenn J M van der Lande5,6
1Sleep Medicine Center, Chongqing Traditional Chinese Medicine Hospital, Chongqing, 400021, China.
Study Objectives:
Event-related potential (ERP) studies on attentional brain processes in insomnia disorder (ID) have yielded inconsistent findings. Such inconsistencies may relate to small sample sizes, limited corrections for multiple comparisons, and the possibility of heterogeneity within the clinical population. We aimed to overcome these limitations by studying ERP responses both across and within subtypes in a larger sample of ID.
Methods:
ERPs were recorded in 201 participants with ID and 70 normal sleeper controls (NS) with an auditory oddball task. Participants with ID were subtyped using a validated multivariate trait profile. Analyses evaluated subtype-specific and nonspecific deviations using both conventional ERP components as well as cluster-based permutation tests.
Results:
All five subtypes were well-represented in the ID sample (subtypes 1-5 respectively N = 31, 83, 28, 29 and 19). ERP component analyses with false discovery rate corrections revealed no evidence for differences between the heterogeneous ID group and NS. However, subtype-specific analyses revealed that ERPs were significantly altered, but in different ways for different subtypes. Specifically, ERP component analyses revealed stronger N100 amplitudes for standards and deviants both in subtypes 2 and 3, and a lower P300 amplitude and longer P300 latency for deviants in subtype 3. Cluster-based permutation tests on ERPs corroborated the P300 amplitude effect for deviants in subtype 3, with subtype 3 and 4 additionally showing a smaller difference between deviant and standard P300 amplitudes.
Conclusion:
Our findings indicate that ID is a heterogeneous disorder. Ignoring subtype identity dilutes ERP alterations occurring only in specific insomnia subtypes.
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Blind Procedures


